nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluvastatin—CYP1A1—Riluzole—amyotrophic lateral sclerosis	0.545	0.691	CbGbCtD
Fluvastatin—CYP1A2—Riluzole—amyotrophic lateral sclerosis	0.243	0.309	CbGbCtD
Fluvastatin—VIIth nerve paralysis—Riluzole—amyotrophic lateral sclerosis	0.00925	0.0502	CcSEcCtD
Fluvastatin—Tooth disorder—Riluzole—amyotrophic lateral sclerosis	0.00585	0.0317	CcSEcCtD
Fluvastatin—Blood creatine phosphokinase increased—Riluzole—amyotrophic lateral sclerosis	0.00551	0.0299	CcSEcCtD
Fluvastatin—Arthropathy—Riluzole—amyotrophic lateral sclerosis	0.00417	0.0226	CcSEcCtD
Fluvastatin—Cataract—Riluzole—amyotrophic lateral sclerosis	0.00399	0.0216	CcSEcCtD
Fluvastatin—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00314	0.017	CcSEcCtD
Fluvastatin—Vascular purpura—Riluzole—amyotrophic lateral sclerosis	0.00308	0.0167	CcSEcCtD
Fluvastatin—Eczema—Riluzole—amyotrophic lateral sclerosis	0.00306	0.0166	CcSEcCtD
Fluvastatin—Injury—Riluzole—amyotrophic lateral sclerosis	0.003	0.0163	CcSEcCtD
Fluvastatin—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00293	0.0159	CcSEcCtD
Fluvastatin—Atrial fibrillation—Riluzole—amyotrophic lateral sclerosis	0.00291	0.0158	CcSEcCtD
Fluvastatin—Purpura—Riluzole—amyotrophic lateral sclerosis	0.00286	0.0155	CcSEcCtD
Fluvastatin—Arthritis—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0154	CcSEcCtD
Fluvastatin—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00275	0.0149	CcSEcCtD
Fluvastatin—Face oedema—Riluzole—amyotrophic lateral sclerosis	0.00266	0.0144	CcSEcCtD
Fluvastatin—Breast disorder—Riluzole—amyotrophic lateral sclerosis	0.00249	0.0135	CcSEcCtD
Fluvastatin—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00244	0.0132	CcSEcCtD
Fluvastatin—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00243	0.0132	CcSEcCtD
Fluvastatin—Influenza—Riluzole—amyotrophic lateral sclerosis	0.00238	0.0129	CcSEcCtD
Fluvastatin—Pancreatitis—Riluzole—amyotrophic lateral sclerosis	0.00233	0.0127	CcSEcCtD
Fluvastatin—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00229	0.0124	CcSEcCtD
Fluvastatin—Erectile dysfunction—Riluzole—amyotrophic lateral sclerosis	0.00219	0.0119	CcSEcCtD
Fluvastatin—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00217	0.0118	CcSEcCtD
Fluvastatin—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0115	CcSEcCtD
Fluvastatin—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0115	CcSEcCtD
Fluvastatin—Neuropathy peripheral—Riluzole—amyotrophic lateral sclerosis	0.00208	0.0113	CcSEcCtD
Fluvastatin—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00206	0.0112	CcSEcCtD
Fluvastatin—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00203	0.011	CcSEcCtD
Fluvastatin—Hepatobiliary disease—Riluzole—amyotrophic lateral sclerosis	0.00201	0.0109	CcSEcCtD
Fluvastatin—Sinusitis—Riluzole—amyotrophic lateral sclerosis	0.00199	0.0108	CcSEcCtD
Fluvastatin—Rhinitis—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0104	CcSEcCtD
Fluvastatin—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0103	CcSEcCtD
Fluvastatin—Hypoaesthesia—Riluzole—amyotrophic lateral sclerosis	0.0019	0.0103	CcSEcCtD
Fluvastatin—Pharyngitis—Riluzole—amyotrophic lateral sclerosis	0.00189	0.0103	CcSEcCtD
Fluvastatin—Oedema peripheral—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0102	CcSEcCtD
Fluvastatin—Connective tissue disorder—Riluzole—amyotrophic lateral sclerosis	0.00187	0.0102	CcSEcCtD
Fluvastatin—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.0018	0.00977	CcSEcCtD
Fluvastatin—Cardiac disorder—Riluzole—amyotrophic lateral sclerosis	0.00177	0.00959	CcSEcCtD
Fluvastatin—Angiopathy—Riluzole—amyotrophic lateral sclerosis	0.00173	0.00938	CcSEcCtD
Fluvastatin—Immune system disorder—Riluzole—amyotrophic lateral sclerosis	0.00172	0.00933	CcSEcCtD
Fluvastatin—Chills—Riluzole—amyotrophic lateral sclerosis	0.00171	0.00927	CcSEcCtD
Fluvastatin—Arrhythmia—Riluzole—amyotrophic lateral sclerosis	0.0017	0.00923	CcSEcCtD
Fluvastatin—Alopecia—Riluzole—amyotrophic lateral sclerosis	0.00168	0.00913	CcSEcCtD
Fluvastatin—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00167	0.00905	CcSEcCtD
Fluvastatin—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00163	0.00886	CcSEcCtD
Fluvastatin—Dysgeusia—Riluzole—amyotrophic lateral sclerosis	0.00162	0.00881	CcSEcCtD
Fluvastatin—Back pain—Riluzole—amyotrophic lateral sclerosis	0.0016	0.0087	CcSEcCtD
Fluvastatin—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00159	0.00865	CcSEcCtD
Fluvastatin—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00155	0.00843	CcSEcCtD
Fluvastatin—Ill-defined disorder—Riluzole—amyotrophic lateral sclerosis	0.00154	0.00835	CcSEcCtD
Fluvastatin—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00152	0.00822	CcSEcCtD
Fluvastatin—Malaise—Riluzole—amyotrophic lateral sclerosis	0.0015	0.00811	CcSEcCtD
Fluvastatin—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00808	CcSEcCtD
Fluvastatin—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00149	0.00807	CcSEcCtD
Fluvastatin—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.00148	0.00805	CcSEcCtD
Fluvastatin—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00146	0.00791	CcSEcCtD
Fluvastatin—Cough—Riluzole—amyotrophic lateral sclerosis	0.00145	0.00785	CcSEcCtD
Fluvastatin—Hypertension—Riluzole—amyotrophic lateral sclerosis	0.00143	0.00777	CcSEcCtD
Fluvastatin—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00766	CcSEcCtD
Fluvastatin—Arthralgia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00766	CcSEcCtD
Fluvastatin—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00766	CcSEcCtD
Fluvastatin—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.00141	0.00763	CcSEcCtD
Fluvastatin—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00761	CcSEcCtD
Fluvastatin—Discomfort—Riluzole—amyotrophic lateral sclerosis	0.0014	0.00757	CcSEcCtD
Fluvastatin—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0074	CcSEcCtD
Fluvastatin—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00135	0.00734	CcSEcCtD
Fluvastatin—Infection—Riluzole—amyotrophic lateral sclerosis	0.00134	0.00729	CcSEcCtD
Fluvastatin—Shock—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00722	CcSEcCtD
Fluvastatin—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.00133	0.0072	CcSEcCtD
Fluvastatin—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00133	0.00719	CcSEcCtD
Fluvastatin—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.00131	0.00713	CcSEcCtD
Fluvastatin—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00131	0.0071	CcSEcCtD
Fluvastatin—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00129	0.007	CcSEcCtD
Fluvastatin—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00123	0.00669	CcSEcCtD
Fluvastatin—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00664	CcSEcCtD
Fluvastatin—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00122	0.00659	CcSEcCtD
Fluvastatin—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00121	0.00655	CcSEcCtD
Fluvastatin—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.00119	0.00646	CcSEcCtD
Fluvastatin—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00118	0.00638	CcSEcCtD
Fluvastatin—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00634	CcSEcCtD
Fluvastatin—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00117	0.00633	CcSEcCtD
Fluvastatin—Pain—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00628	CcSEcCtD
Fluvastatin—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00116	0.00628	CcSEcCtD
Fluvastatin—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00112	0.00605	CcSEcCtD
Fluvastatin—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.00111	0.006	CcSEcCtD
Fluvastatin—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00108	0.00583	CcSEcCtD
Fluvastatin—Abdominal pain—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0058	CcSEcCtD
Fluvastatin—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0058	CcSEcCtD
Fluvastatin—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.000997	0.00541	CcSEcCtD
Fluvastatin—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000971	0.00527	CcSEcCtD
Fluvastatin—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000958	0.00519	CcSEcCtD
Fluvastatin—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000926	0.00502	CcSEcCtD
Fluvastatin—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000895	0.00485	CcSEcCtD
Fluvastatin—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000861	0.00467	CcSEcCtD
Fluvastatin—Rash—Riluzole—amyotrophic lateral sclerosis	0.000854	0.00463	CcSEcCtD
Fluvastatin—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.000853	0.00462	CcSEcCtD
Fluvastatin—Headache—Riluzole—amyotrophic lateral sclerosis	0.000848	0.0046	CcSEcCtD
Fluvastatin—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00436	CcSEcCtD
Fluvastatin—UGT2B7—Metabolism—FIG4—amyotrophic lateral sclerosis	5.79e-05	0.00211	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PLB1—amyotrophic lateral sclerosis	5.73e-05	0.00208	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.68e-05	0.00207	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	5.67e-05	0.00206	CbGpPWpGaD
Fluvastatin—CYP2C8—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.63e-05	0.00205	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	5.63e-05	0.00205	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	5.57e-05	0.00202	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	5.4e-05	0.00196	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	5.4e-05	0.00196	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	5.39e-05	0.00196	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—GSR—amyotrophic lateral sclerosis	5.29e-05	0.00192	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	5.28e-05	0.00192	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—DAO—amyotrophic lateral sclerosis	5.24e-05	0.0019	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	5.18e-05	0.00188	CbGpPWpGaD
Fluvastatin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	5.17e-05	0.00188	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.03e-05	0.00183	CbGpPWpGaD
Fluvastatin—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	5.03e-05	0.00183	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	5.01e-05	0.00182	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.97e-05	0.00181	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	4.94e-05	0.00179	CbGpPWpGaD
Fluvastatin—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	4.85e-05	0.00176	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	4.84e-05	0.00176	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.82e-05	0.00175	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.81e-05	0.00175	CbGpPWpGaD
Fluvastatin—CYP1A2—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	4.81e-05	0.00175	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.78e-05	0.00174	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.78e-05	0.00174	CbGpPWpGaD
Fluvastatin—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.78e-05	0.00174	CbGpPWpGaD
Fluvastatin—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.71e-05	0.00171	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	4.71e-05	0.00171	CbGpPWpGaD
Fluvastatin—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.67e-05	0.0017	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PLB1—amyotrophic lateral sclerosis	4.67e-05	0.0017	CbGpPWpGaD
Fluvastatin—HMGCR—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	4.67e-05	0.0017	CbGpPWpGaD
Fluvastatin—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.61e-05	0.00168	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.59e-05	0.00167	CbGpPWpGaD
Fluvastatin—CYP2C9—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	4.58e-05	0.00167	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	4.53e-05	0.00165	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	4.43e-05	0.00161	CbGpPWpGaD
Fluvastatin—CYP1A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.41e-05	0.0016	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PLB1—amyotrophic lateral sclerosis	4.4e-05	0.0016	CbGpPWpGaD
Fluvastatin—CYP1A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.35e-05	0.00158	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—CHAT—amyotrophic lateral sclerosis	4.34e-05	0.00158	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	4.31e-05	0.00157	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—GSR—amyotrophic lateral sclerosis	4.31e-05	0.00157	CbGpPWpGaD
Fluvastatin—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.26e-05	0.00155	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—DAO—amyotrophic lateral sclerosis	4.26e-05	0.00155	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—amyotrophic lateral sclerosis	4.19e-05	0.00152	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.16e-05	0.00151	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	4.12e-05	0.0015	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—GSR—amyotrophic lateral sclerosis	4.06e-05	0.00148	CbGpPWpGaD
Fluvastatin—CYP2C8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.05e-05	0.00147	CbGpPWpGaD
Fluvastatin—CYP2C8—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.99e-05	0.00145	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PLB1—amyotrophic lateral sclerosis	3.97e-05	0.00144	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.96e-05	0.00144	CbGpPWpGaD
Fluvastatin—CYP1A2—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	3.92e-05	0.00142	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	3.9e-05	0.00142	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	3.87e-05	0.00141	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.81e-05	0.00139	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.7e-05	0.00134	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—GSR—amyotrophic lateral sclerosis	3.66e-05	0.00133	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	3.66e-05	0.00133	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	3.66e-05	0.00133	CbGpPWpGaD
Fluvastatin—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.61e-05	0.00131	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	3.58e-05	0.0013	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	3.58e-05	0.0013	CbGpPWpGaD
Fluvastatin—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.56e-05	0.0013	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—CHAT—amyotrophic lateral sclerosis	3.54e-05	0.00129	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.4e-05	0.00124	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.38e-05	0.00123	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.38e-05	0.00123	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	3.35e-05	0.00122	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—CHAT—amyotrophic lateral sclerosis	3.33e-05	0.00121	CbGpPWpGaD
Fluvastatin—CYP2D6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.32e-05	0.00121	CbGpPWpGaD
Fluvastatin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	3.3e-05	0.0012	CbGpPWpGaD
Fluvastatin—CYP2C9—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.29e-05	0.0012	CbGpPWpGaD
Fluvastatin—CYP2D6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.28e-05	0.00119	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	3.27e-05	0.00119	CbGpPWpGaD
Fluvastatin—CYP2C9—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.25e-05	0.00118	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	3.23e-05	0.00117	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.15e-05	0.00115	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.11e-05	0.00113	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.1e-05	0.00113	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—TPK1—amyotrophic lateral sclerosis	3.1e-05	0.00113	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—VAPB—amyotrophic lateral sclerosis	3.1e-05	0.00113	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.09e-05	0.00112	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.04e-05	0.00111	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.04e-05	0.00111	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—CHAT—amyotrophic lateral sclerosis	3.01e-05	0.00109	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—GSR—amyotrophic lateral sclerosis	2.98e-05	0.00108	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.96e-05	0.00107	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.93e-05	0.00106	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.89e-05	0.00105	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.88e-05	0.00105	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	2.86e-05	0.00104	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—VAPA—amyotrophic lateral sclerosis	2.84e-05	0.00103	CbGpPWpGaD
Fluvastatin—CYP1A2—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.81e-05	0.00102	CbGpPWpGaD
Fluvastatin—CYP1A2—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.78e-05	0.00101	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	2.77e-05	0.00101	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	2.77e-05	0.00101	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	2.73e-05	0.000992	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.71e-05	0.000987	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.7e-05	0.000983	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	2.65e-05	0.000965	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	2.65e-05	0.000963	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.64e-05	0.000959	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	2.59e-05	0.000941	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.58e-05	0.000938	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—VAPB—amyotrophic lateral sclerosis	2.55e-05	0.000926	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—TPK1—amyotrophic lateral sclerosis	2.55e-05	0.000926	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	2.53e-05	0.00092	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—VAPB—amyotrophic lateral sclerosis	2.52e-05	0.000918	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—TPK1—amyotrophic lateral sclerosis	2.52e-05	0.000918	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.48e-05	0.000903	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—FIG4—amyotrophic lateral sclerosis	2.48e-05	0.000901	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.45e-05	0.000889	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—DAO—amyotrophic lateral sclerosis	2.45e-05	0.000889	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.35e-05	0.000856	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.35e-05	0.000855	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.33e-05	0.000848	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—VAPA—amyotrophic lateral sclerosis	2.33e-05	0.000846	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—VAPA—amyotrophic lateral sclerosis	2.31e-05	0.000839	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—DAO—amyotrophic lateral sclerosis	2.24e-05	0.000815	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	2.24e-05	0.000815	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	2.21e-05	0.000804	CbGpPWpGaD
Fluvastatin—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.17e-05	0.00079	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.16e-05	0.000787	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—VAPB—amyotrophic lateral sclerosis	2.16e-05	0.000784	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—TPK1—amyotrophic lateral sclerosis	2.16e-05	0.000784	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.15e-05	0.00078	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.14e-05	0.00078	CbGpPWpGaD
Fluvastatin—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.14e-05	0.000779	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.08e-05	0.000758	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.04e-05	0.000743	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—FIG4—amyotrophic lateral sclerosis	2.03e-05	0.00074	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—FIG4—amyotrophic lateral sclerosis	2.02e-05	0.000733	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.01e-05	0.000731	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.01e-05	0.00073	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2e-05	0.000727	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—VAPA—amyotrophic lateral sclerosis	1.97e-05	0.000717	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.96e-05	0.000713	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.9e-05	0.000692	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.85e-05	0.000674	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	1.85e-05	0.000673	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—DAO—amyotrophic lateral sclerosis	1.84e-05	0.000669	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.83e-05	0.000667	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—DAO—amyotrophic lateral sclerosis	1.82e-05	0.000663	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.81e-05	0.000658	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.79e-05	0.000652	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—APOE—amyotrophic lateral sclerosis	1.76e-05	0.000641	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.75e-05	0.000635	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—FIG4—amyotrophic lateral sclerosis	1.72e-05	0.000627	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSR—amyotrophic lateral sclerosis	1.71e-05	0.000622	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PLB1—amyotrophic lateral sclerosis	1.7e-05	0.000618	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	1.66e-05	0.000605	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	1.66e-05	0.000605	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.65e-05	0.000599	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.62e-05	0.000588	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSR—amyotrophic lateral sclerosis	1.57e-05	0.00057	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—DAO—amyotrophic lateral sclerosis	1.56e-05	0.000567	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.56e-05	0.000566	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.52e-05	0.000553	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.52e-05	0.000553	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.52e-05	0.000551	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.49e-05	0.00054	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.49e-05	0.00054	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—APOE—amyotrophic lateral sclerosis	1.44e-05	0.000523	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.43e-05	0.000519	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.42e-05	0.000515	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.4e-05	0.000511	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.4e-05	0.000509	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.4e-05	0.000509	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PLB1—amyotrophic lateral sclerosis	1.39e-05	0.000507	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PLB1—amyotrophic lateral sclerosis	1.38e-05	0.000503	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—APOE—amyotrophic lateral sclerosis	1.36e-05	0.000493	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.33e-05	0.000484	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.31e-05	0.000478	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—CHAT—amyotrophic lateral sclerosis	1.29e-05	0.000468	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSR—amyotrophic lateral sclerosis	1.29e-05	0.000468	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.28e-05	0.000466	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSR—amyotrophic lateral sclerosis	1.28e-05	0.000464	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.27e-05	0.000463	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—APOE—amyotrophic lateral sclerosis	1.22e-05	0.000445	CbGpPWpGaD
Fluvastatin—HMGCR—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.21e-05	0.000439	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.21e-05	0.000439	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.2e-05	0.000438	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.2e-05	0.000437	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.18e-05	0.00043	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.17e-05	0.000427	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.16e-05	0.000423	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.15e-05	0.000418	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.11e-05	0.000402	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSR—amyotrophic lateral sclerosis	1.09e-05	0.000396	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.06e-05	0.000384	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.05e-05	0.000381	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—CHAT—amyotrophic lateral sclerosis	1.05e-05	0.000381	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—APOE—amyotrophic lateral sclerosis	9.94e-06	0.000361	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	9.93e-06	0.000361	CbGpPWpGaD
Fluvastatin—UGT1A3—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.85e-06	0.000358	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	9.56e-06	0.000348	CbGpPWpGaD
Fluvastatin—SLCO1B3—Metabolism—PTGS2—amyotrophic lateral sclerosis	9.29e-06	0.000338	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	9.12e-06	0.000332	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	9.1e-06	0.000331	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—CHAT—amyotrophic lateral sclerosis	8.95e-06	0.000326	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.78e-06	0.000319	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	8.42e-06	0.000306	CbGpPWpGaD
Fluvastatin—UGT2B7—Metabolism—PTGS2—amyotrophic lateral sclerosis	8.38e-06	0.000305	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.17e-06	0.000297	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	8.17e-06	0.000297	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.05e-06	0.000293	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.99e-06	0.00029	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.55e-06	0.000274	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.51e-06	0.000273	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.34e-06	0.000267	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	7.18e-06	0.000261	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.94e-06	0.000252	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.92e-06	0.000252	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	6.91e-06	0.000251	CbGpPWpGaD
Fluvastatin—UGT1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.81e-06	0.000248	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	6.55e-06	0.000238	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.36e-06	0.000231	CbGpPWpGaD
Fluvastatin—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.24e-06	0.000227	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	6.18e-06	0.000225	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.18e-06	0.000225	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	6.04e-06	0.00022	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—APOE—amyotrophic lateral sclerosis	5.71e-06	0.000207	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.68e-06	0.000207	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.68e-06	0.000206	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—GSTP1—amyotrophic lateral sclerosis	5.63e-06	0.000205	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	5.6e-06	0.000204	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—APOE—amyotrophic lateral sclerosis	5.23e-06	0.00019	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.22e-06	0.00019	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.18e-06	0.000188	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.81e-06	0.000175	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	4.67e-06	0.00017	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.42e-06	0.000161	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—APOE—amyotrophic lateral sclerosis	4.3e-06	0.000156	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—APOE—amyotrophic lateral sclerosis	4.26e-06	0.000155	CbGpPWpGaD
Fluvastatin—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.23e-06	0.000154	CbGpPWpGaD
Fluvastatin—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.14e-06	0.00015	CbGpPWpGaD
Fluvastatin—CYP1A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.91e-06	0.000142	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.71e-06	0.000135	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—APOE—amyotrophic lateral sclerosis	3.64e-06	0.000132	CbGpPWpGaD
Fluvastatin—CYP2C8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.58e-06	0.00013	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.41e-06	0.000124	CbGpPWpGaD
Fluvastatin—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.2e-06	0.000116	CbGpPWpGaD
Fluvastatin—CYP2D6—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.94e-06	0.000107	CbGpPWpGaD
Fluvastatin—CYP2C9—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.92e-06	0.000106	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	2.81e-06	0.000102	CbGpPWpGaD
Fluvastatin—CYP1A2—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.49e-06	9.07e-05	CbGpPWpGaD
Fluvastatin—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.92e-06	7e-05	CbGpPWpGaD
